Figure 1.
Median overall survival in PACCE and CAIRO2. Bev: bevacizumab; Cap: capecitabine; Cmab: cetuximab; Iri: irinotecan; Ox: oxaliplatin; Pmab: panitumumab.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.